Company: AGIO
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0001193125-25-096719
Chunk: 43

Company: AGIOS PHARMACEUTICALS, INC.
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 43
---
 on page 62 of this Proxy Statement; and |

| • |     | reviewing and discussing with management human resource policies and practices, including those related to talent acquisition and retention, key diversity initiatives, career development and organizational engagement and effectiveness. |

Nominating and Corporate Governance Committee The members of our nominating and corporate governance committee are Ms. Foster, Dr. Ho and Dr. Scadden. Ms. Foster is the chair of the nominating and corporate governance committee. The nominating and corporate governance committee met three times during fiscal year 2024, including telephonic and virtual meetings. The nominating and corporate governance committee’s responsibilities include:

| • |     | identifying individuals qualified to become board members; |

| • |     | recommending to our board of directors the persons to be nominated for election as directors and to each committee of our board of directors; |

| • |     | reviewing and making recommendations to the board of directors with respect to management succession planning and human capital matters; |

| • |     | developing and recommending corporate governance principles to the board of directors; |

| • |     | overseeing an annual self-evaluation of the board of directors; and |

| • |     | overseeing our programs, policies, disclosures and practices relating to ESG issues and impact to support the sustainable growth of our business. |

The processes and procedures followed by our nominating and corporate governance committee in identifying and evaluating director candidates are described above under the heading “Director Nomination Process”. Science and Technology Committee The members of our science and technology committee are Dr. Ballal, Dr. Scadden and Dr. Fouse. Dr. Scadden is the chair of the science and technology committee. The science and technology committee assists our board’s oversight of our research and development activities. The science and technology committee met three times during fiscal year 2024, including telephonic and virtual meetings. The science and technology committee’s responsibilities include:

| • |     | reviewing, evaluating, and advising our board of directors and management regarding our long-term strategic goals and objectives and the quality and direction of our research and development programs; |

30

| • |     | monitoring and evaluating trends in research and development, and recommending to our board of directors and management emerging technologies for building the company’s technological strength; |

| • |     | recommending approaches to acquiring and maintaining technology positions (including but not limited to contracts, grants, collaborative efforts, alliances, and capital); |

| • |     | advising our board of directors and management on the